Since 2021, she has managed seven tissue and cell banks and led the implementation of the ISO 20387 standard for biobanks, in collaboration with the Biobanking and BioMolecular Resources Research Infrastructure and the Belgian Accreditation Body. Edith also chairs the Quality Assurance Systems Commission.
Previously, as the Head of Quality Assurance, Regulatory Affairs, and Innovation at the same hospital, she led the construction of the new In Vitro Fertilization (IVF) platform and the federal platform during the health crisis. She oversaw the certification of more than 12 entities and led innovative healthcare projects.
Prior to joining Saint-Luc, Edith held the position of Validation Manager at Pfizer. In this role, she was responsible for ensuring that global systems were validated and met the stringent requirements of cGMP and FDA regulations. Her extensive international experience spans over 8 countries, including the United States, Brazil, France, and Australia. Additionally, she contributed to SKEYES as their Testing and Validation Manager, where she was instrumental in developing strategies for the CANAC program.
Edith holds a Master's in Administration and Management and a Bachelor's in Economics from the Université Catholique de Louvain, and she also earned a Bachelor's in Economics at the University of Costa Rica.
Plastic Surgeon, MBA in Business Administration with a postgraduate degree in Health. Master in Public Health, Master's in Major Burns, Diploma in Tissue Banks
Currently part of the Skin and Tissue Bank of Tarapacá, Iquique, Chile, and pursuing a PhD in Surgery and Morphological Sciences at the Autonomous University of Barcelona, Barcelona, Spain.
With more than 20 years of experience in the field of tissue donation, Martin Börgel is the current President of the European Association for Tissue and Cell Banks (EATCB) and the General Secretary of the World Union of Tissue Banking Associations (WUTBA). Since 2002, Martin Börgel has been Managing Director of the German Society for Tissue Transplantation-DGFG.
Martin Börgel's professional life began with training as a pediatric nurse. He worked for two years at the St. Franziskus Hospital in Münster while simultaneously pursuing a degree in business administration with a specialization in healthcare at Osnabrück University. After receiving his diploma, he transitioned to a role as an auditor for Solidaris Unternehmensberatung Köln for several years. There, he was responsible for expert audits of the Eurotransplant and DSO foundations. This intensive experience proved invaluable, as he was involved in the restructuring and development of the German Organ Transplantation Foundation and the establishment of its subsidiary responsible for tissue donation. Ultimately, this background led him to his current position as Managing Director of Germany's largest tissue establishment, the DGFG. The DGFG facilitates half of all cornea, heart valve, blood vessel, and amniotic membrane transplants performed in Germany.